Moderna, Inc. (0QF.MU)
Develops messenger RNA vaccines and treatments for infectious diseases and cancer.
48.53+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+85.2%
The outlook
Moderna is trading near the middle of its 52-week range, showing mixed momentum against its moving averages. Analyst sentiment leans slightly bullish overall, though price action today is flat. The stock sits in a neutral technical position without clear directional conviction at present levels.
What’s behind the score
Price trendMixed vs its moving averages
52-week range55% of the way from its 52-week low to high
Market cap
$19.25B
52-wk high
71.88
52-wk low
19.59
50-day avg
51.09
200-day avg
38.73
Trailing P/E
—